Related references
Note: Only part of the references are listed.Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients
Giuliana Guggino et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+T Cells in Psoriatic Arthritis
Kathryn J. A. Steel et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis
Frank Penkava et al.
NATURE COMMUNICATIONS (2020)
T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3+Th2 phenotype
Jonathan Aldridge et al.
ARTHRITIS RESEARCH & THERAPY (2020)
IDENTIFICATION OF OSTEOPONTIN/SECRETED PHOSPHOPROTEIN 1 AS A BIOMARKER FOR PSORIATIC ARTHRITIS
F. Abji et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
Fan Zhang et al.
NATURE IMMUNOLOGY (2019)
Integrin and transcriptomic profiles identify a distinctive synovial CD8+T cell subpopulation in spondyloarthritis
Zoya Qaiyum et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Martha Gschwandtner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study
Alejandro Gomez-Aristizabal et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Psoriatic arthritis 1 The pathogenesis of psoriatic arthritis
Douglas J. Veale et al.
LANCET (2018)
Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities
Vahid Farrokhi et al.
SCIENTIFIC REPORTS (2018)
Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients
W. E. O'Gorman et al.
JOURNAL OF AUTOIMMUNITY (2017)
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
Deepak A. Rao et al.
NATURE (2017)
Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
M. H. Al-Mossawi et al.
NATURE COMMUNICATIONS (2017)
IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis
Eric Gracey et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Gene-specific correlation of RNA and protein levels in human cells and tissues
Fredrik Edfors et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo
Elena Boggio et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis
Anastasiya Muntyanu et al.
ARTHRITIS RESEARCH & THERAPY (2016)
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen et al.
CYTOMETRY PART A (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis
Marzia Dolcino et al.
PLOS ONE (2015)
Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
Keisuke Izumi et al.
PLOS ONE (2015)
Functional Phenotype of Synovial Monocytes Modulating Inflammatory T-Cell Responses in Rheumatoid Arthritis (RA)
Bo Ruem Yoon et al.
PLOS ONE (2014)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study
M. J. H. Boumans et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Michael Yellin et al.
ARTHRITIS AND RHEUMATISM (2012)
Role of Osteopontin in Synovial Th17 Differentiation in Rheumatoid Arthritis
Guangjie Chen et al.
ARTHRITIS AND RHEUMATISM (2010)
Role of Osteopontin in Induction of Monocyte Chemoattractant Protein 1 and Macrophage Inflammatory Protein 1 beta Through the NF-kappa B and MAPK Pathways in Rheumatoid Arthritis
Wenxin Zheng et al.
ARTHRITIS AND RHEUMATISM (2009)
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis
Alessandro Antonelli et al.
AUTOIMMUNITY (2008)
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2008)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
SL Jongbloed et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy
D Baeten et al.
ARTHRITIS RESEARCH & THERAPY (2005)
CD14+,CD16+blood monocytes and joint inflammation in rheumatoid arthritis
N Kawanaka et al.
ARTHRITIS AND RHEUMATISM (2002)
A subset of natural killer cells is greatly expanded within inflamed joints
N Dalbeth et al.
ARTHRITIS AND RHEUMATISM (2002)
Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-α production
A Guglielmotti et al.
INFLAMMATION RESEARCH (2002)
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF
KU Belge et al.
JOURNAL OF IMMUNOLOGY (2002)
Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy
D Baeten et al.
JOURNAL OF PATHOLOGY (2002)
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
PJ Mease et al.
LANCET (2000)
Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
S Ashkar et al.
SCIENCE (2000)
Share Paper
